Abstract: A device including an implantable assembly. The assembly includes a bone fixture configured to anchor to bone of a recipient, and a vibratory apparatus configured to be completely implanted beneath the skin of a recipient, wherein the implantable assembly is configured such that the vibratory apparatus can move relative to the bone fixture while implanted in a recipient.

Abstract: The sound processor and method uses a model of basilar membrane motion to select stimuli, based upon the predicted motion which the acoustic signal presented would produce in an acoustically excited normally hearing cochlea. The filter; used, in contrast to single channel per electrode approaches, cover multiple channels and overlap with each other. Consequently the stimuli presented produce a neural excitation pattern which approximates the spatio-temporal travelling wave observed on the basilar membrane in an acoustically excited normally hearing cochlea. Preferably, the predicted electrode stimuli are based upon the instantaneous predicted amplitude of the electrode location.

Abstract: A stimulating medical device comprising a stimulating assembly implantable proximate to nerve cells of a recipient having at least one agent delivery port and a plurality of electrical contacts; an electrical stimulation controller configured to generate electrical stimulation signals for application to a first population of the nerve cells via one or more of the plurality of electrical contacts; a pharmaceutical agent source configured to provide a pharmaceutical agent to the at least one delivery port for application to a second population of the nerve cells; and a pharmaceutical agent controller configured to control one or more of the pharmaceutical agent source and the at least one delivery port to cause selective application of the pharmaceutical agent to the second population of nerve cells.

Abstract: A stimulating medical device comprising a stimulating assembly implantable proximate to nerve cells of a recipient having at least one agent delivery port and a plurality of electrical contacts; an electrical stimulation controller configured to generate electrical stimulation signals for application to a first population of the nerve cells via one or more of the plurality of electrical contacts; a pharmaceutical agent source configured to provide a pharmaceutical agent to the at least one delivery port for application to a second population of the nerve cells; and a pharmaceutical agent controller configured to control one or more of the pharmaceutical agent source and the at least one delivery port to cause selective application of the pharmaceutical agent to the second population of nerve cells.

Abstract: An implantable stimulation device is disclosed which provides for reduced power consumption when compared with bipolar stimulation and better stimulation performance when compared with monopolar stimulation. Implantable stimulator devices use less power in monopolar stimulation mode than that of bipolar stimulation but stimulation performance is greater when using bipolar stimulation. The device comprises circuitry capable of simultaneous stimulation between a reference electrode and an electrode of a stimulation array and between electrodes of the stimulation array, the ratio of current to the reference electrode and array electrodes being selectable.

Abstract: A neural-stimulating device for stimulating nerve cells of a recipient is provided. The neural-stimulating device comprises an electromagnetic radiation source configured to generate one or more optical stimulation signals and an electrical stimulation generator configured to generate electrical stimulation signals. The neural-stimulating device also comprises an implantable stimulating assembly configured to be implanted in the recipient, and having disposed thereon an optical contact to deliver the one or more optical stimulation signals to the nerve cells, and an electrical contact to deliver the electric stimulation signals to the nerve cells.

Abstract: A neural-stimulating device for stimulating nerve cells of a recipient is provided. The neural-stimulating device comprises an electromagnetic radiation source configured to generate one or more optical stimulation signals and an electrical stimulation generator configured to generate electrical stimulation signals. The neural-stimulating device also comprises an implantable stimulating assembly configured to be implanted in the recipient, and having disposed thereon an optical contact to deliver the one or more optical stimulation signals to the nerve cells, and an electrical contact to deliver the electric stimulation signals to the nerve cells.

Abstract: An embodiment of the present invention takes masking effects into consideration when determining stimulation signals for neural stimulation. These masking effects may be modeled using user-specific models determined by taking measurements for an implant system of an implant recipient. Or, the model may correspond to a group of individuals sharing a common characteristic or the population as a whole. These models may be, for example, psycho-physical models.

Abstract: A method and apparatus for detecting an envelope of an audio signal, and a method and apparatus for enhancing the pitch cue of an audio signal perceived by a cochlear implant patient where the audio signal is processed and input to an implant device of the recipient. The methods and apparatuses use techniques such as filtering, rectifying, detecting peak values, sampling, resetting, comparing and multiplying various signals to detect the envelope or enhance the pitch cue of the audio signal.

Abstract: A method and device are disclosed for neural stimulation with improved power consumption and/or effectiveness. The stimulus generator is arranged, for example via a look up table, to recognise proposed stimuli which will be masked by earlier or simultaneous stimuli. Such masked stimuli are either deleted, or replaced by another stimulus.

Abstract: Neural stimulation device with improved power consumption and/or effectiveness. The device is configured to recognize proposed stimuli which will be masked by earlier or simultaneous stimuli. Such masked stimuli are either deleted, or replaced by another stimuli.

Abstract: A medical implant having an electrically conductive region for stimulating tissue of a user or patient. The electrically conductive region is coated with a self assembled monolayer (SAM) which at least inhibits the attachment of impedance-inducing material such as protein, cells or fibrous tissue, to the electrically conductive region.

Abstract: A stimulating medical device comprising a stimulating assembly implantable proximate to nerve cells of a recipient having at least one agent delivery port and a plurality of electrical contacts; an electrical stimulation controller configured to generate electrical stimulation signals for application to a first population of the nerve cells via one or more of the plurality of electrical contacts; a pharmaceutical agent source configured to provide a pharmaceutical agent to the at least one delivery port for application to a second population of the nerve cells; and a pharmaceutical agent controller configured to control one or more of the pharmaceutical agent source and the at least one delivery port to cause selective application of the pharmaceutical agent to the second population of nerve cells.

Abstract: A cochlear implant is provided. The cochlear implant comprises a stimulator unit configured to generate electrical stimulation signals based on sound processor-encoded signals, and to generate one or more optical stimulation signals, and an implantable stimulating assembly. The implantable stimulating assembly is configured to be implanted into a basal region of a recipient's cochlea such that when the stimulating assembly is fully implanted, a distal end of the assembly extends to the basal turn of the cochlea. The stimulating assembly also comprises: an optical contact to deliver the one or more optical stimulation signals to the cochlea, and an electrical contact to deliver the electric stimulation signals to a basal region of the cochlea so as to cause perception by the recipient of one or more frequency components of the acoustic sound signal.

Abstract: A neural-stimulating device for stimulating nerve cells of a recipient is provided. The neural-stimulating device comprises an electromagnetic radiation (EMR) generator configured to generate one or more optical stimulation signals configured to cause pseudospontaneous activity; and an implantable stimulating assembly having an optical contact coupled to the EMR generator, the stimulating assembly configured to be implanted in the recipient such that the one or more optical stimulation signals are applied to the nerve cells via the optical contact.

Abstract: A neural-stimulating device for stimulating nerve cells of a recipient is provided. The neural-stimulating device comprises an electromagnetic radiation source configured to generate one or more optical stimulation signals and an electrical stimulation generator configured to generate electrical stimulation signals. The neural-stimulating device also comprises an implantable stimulating assembly configured to be implanted in the recipient, and having disposed thereon an optical contact to deliver the one or more optical stimulation signals to the nerve cells, and an electrical contact to deliver the electric stimulation signals to the nerve cells.

Abstract: A method and apparatus for detecting an envelope of an audio signal, and a method and apparatus for enhancing the pitch cue of an audio signal perceived by a cochlear implant patient where the audio signal is processed and input to an implant device of the recipient. The methods and apparatuses use techniques such as filtering, rectifying, detecting peak values, sampling, resetting, comparing and multiplying various signals to detect the envelope or enhance the pitch cue of the audio signal.

Abstract: A method and device are disclosed for neural stimulation with improved power consumption and/or effectiveness. The stimulus generator is arranged, for example via a look up table, to recognize proposed stimuli which will be masked by earlier or simultaneous stimuli. Such masked stimuli are either deleted, or replaced by another stimulus.

Abstract: The sound processor and method uses a model of basilar membrane motion to select stimuli, based upon the predicted motion which the acoustic signal presented would produce in an acoustically excited normally hearing cochlea. The filter; used, in contrast to single channel per electrode approaches, cover multiple channels and overlap with each other. Consequently the stimuli presented produce a neural excitation pattern which approximates the spatio-temporal travelling wave observed on the basilar membrane in an acoustically excited normally hearing cochlea. Preferably, the predicted electrode stimuli are based upon the instantaneous predicted amplitude of the electrode location.

Abstract: The sound processor and method uses a model of basilar membrane motion to select stimuli, based upon the predicted motion which the acoustic signal presented would produce in an acoustically excited normally hearing cochlea. The filter; used, in contrast to single channel per electrode approaches, cover multiple channels and overlap with each other. Consequently the stimuli presented produce a neural excitation pattern which approximates the spatio-temporal travelling wave observed on the basilar membrane in an acoustically excited normally hearing cochlea. Preferably, the predicted electrode stimuli are based upon the instantaneous predicted amplitude of the electrode location.